These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 21610682)

  • 1. New short interfering RNA-based therapies for glomerulonephritis.
    Shimizu H; Fujita T
    Nat Rev Nephrol; 2011 May; 7(7):407-15. PubMed ID: 21610682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA-based therapy ameliorates glomerulonephritis.
    Shimizu H; Hori Y; Kaname S; Yamada K; Nishiyama N; Matsumoto S; Miyata K; Oba M; Yamada A; Kataoka K; Fujita T
    J Am Soc Nephrol; 2010 Apr; 21(4):622-33. PubMed ID: 20203158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemically modified siRNA prolonged RNA interference in renal disease.
    Takabatake Y; Isaka Y; Mizui M; Kawachi H; Takahara S; Imai E
    Biochem Biophys Res Commun; 2007 Nov; 363(2):432-7. PubMed ID: 17880921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic face of RNAi: in vivo challenges.
    Borna H; Imani S; Iman M; Azimzadeh Jamalkandi S
    Expert Opin Biol Ther; 2015 Feb; 15(2):269-85. PubMed ID: 25399911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Journey of siRNA: Clinical Developments and Targeted Delivery.
    Nikam RR; Gore KR
    Nucleic Acid Ther; 2018 Aug; 28(4):209-224. PubMed ID: 29584585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promising approaches of small interfering RNAs (siRNAs) mediated cancer gene therapy.
    Senapati D; Patra BC; Kar A; Chini DS; Ghosh S; Patra S; Bhattacharya M
    Gene; 2019 Nov; 719():144071. PubMed ID: 31454539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application.
    Jackson AL; Linsley PS
    Nat Rev Drug Discov; 2010 Jan; 9(1):57-67. PubMed ID: 20043028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Interfering RNAs and their Delivery Systems: A Novel Powerful Tool for the Potential Treatment of HIV Infections.
    Bolhassani A; Milani A
    Curr Mol Pharmacol; 2020; 13(3):173-181. PubMed ID: 31760929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. siRNA: novel therapeutics from functional genomics.
    Joshi BH; Pachchigar KP
    Biotechnol Genet Eng Rev; 2014 Oct; 30(1-2):1-30. PubMed ID: 25023460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
    Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
    Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo gene silencing following non-invasive siRNA delivery into the skin using a novel topical formulation.
    Hegde V; Hickerson RP; Nainamalai S; Campbell PA; Smith FJ; McLean WH; Pedrioli DM
    J Control Release; 2014 Dec; 196():355-62. PubMed ID: 25449884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.
    Guzman-Aranguez A; Loma P; Pintor J
    Br J Pharmacol; 2013 Oct; 170(4):730-47. PubMed ID: 23937539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research progress on siRNA delivery with nonviral carriers.
    Gao Y; Liu XL; Li XR
    Int J Nanomedicine; 2011; 6():1017-25. PubMed ID: 21720513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene silencing mediated by small interfering RNAs in mammalian cells.
    Scherr M; Morgan MA; Eder M
    Curr Med Chem; 2003 Feb; 10(3):245-56. PubMed ID: 12570711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancements in small interfering RNAs therapy for acute lymphoblastic leukemia: promising results and future perspectives.
    Rastgar A; Kheyrandish S; Vahidi M; Heidari R; Ghorbani M
    Mol Biol Rep; 2024 Jun; 51(1):737. PubMed ID: 38874790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-Regulated Functionalized Liposome-Nanoparticle Hybrids Loaded with Dexamethasone/TGFβ1-siRNA for Targeted Therapy of Glomerulonephritis.
    Fang P; Han L; Liu C; Deng S; Zhang E; Gong P; Ren Y; Gu J; He L; Yuan ZX
    ACS Appl Mater Interfaces; 2022 Jan; 14(1):307-323. PubMed ID: 34968038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoproteins for the systemic delivery of short interfering RNA.
    McMahon KM; Thaxton CS
    Expert Opin Drug Deliv; 2014 Feb; 11(2):231-47. PubMed ID: 24313310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knocking down disease: a progress report on siRNA therapeutics.
    Wittrup A; Lieberman J
    Nat Rev Genet; 2015 Sep; 16(9):543-52. PubMed ID: 26281785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. siRNA: a potential tool for future breast cancer therapy?
    Størvold GL; Andersen TI; Perou CM; Frengen E
    Crit Rev Oncog; 2006 Jul; 12(1-2):127-50. PubMed ID: 17078209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovations in siRNA research: a technology comes of age.
    Hefferon KL
    Recent Pat Antiinfect Drug Discov; 2010 Nov; 5(3):226-39. PubMed ID: 20812899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.